These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33125371)

  • 1. Mitigation of liquid-liquid phase separation of a monoclonal antibody by mutations of negative charges on the Fab surface.
    Matsuoka T; Miyauchi R; Nagaoka N; Hasegawa J
    PLoS One; 2020; 15(10):e0240673. PubMed ID: 33125371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Process optimization and protein engineering mitigated manufacturing challenges of a monoclonal antibody with liquid-liquid phase separation issue by disrupting inter-molecule electrostatic interactions.
    Du Q; Damschroder M; Pabst TM; Hunter AK; Wang WK; Luo H
    MAbs; 2019; 11(4):789-802. PubMed ID: 30913985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment.
    Kirley TL; Norman AB
    Hum Vaccin Immunother; 2015; 11(2):458-67. PubMed ID: 25692880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc domain mediated self-association of an IgG1 monoclonal antibody under a low ionic strength condition.
    Nishi H; Miyajima M; Wakiyama N; Kubota K; Hasegawa J; Uchiyama S; Fukui K
    J Biosci Bioeng; 2011 Oct; 112(4):326-32. PubMed ID: 21783411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal Structure.
    Chow CK; Allan BW; Chai Q; Atwell S; Lu J
    Mol Pharm; 2016 Mar; 13(3):915-23. PubMed ID: 26849155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theory for the Liquid-Liquid Phase Separation in Aqueous Antibody Solutions.
    Kastelic M; Vlachy V
    J Phys Chem B; 2018 May; 122(21):5400-5408. PubMed ID: 29338267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ionic strength and pH on the physical and chemical stability of a monoclonal antibody antigen-binding fragment.
    Wang T; Kumru OS; Yi L; Wang YJ; Zhang J; Kim JH; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2013 Aug; 102(8):2520-37. PubMed ID: 23824562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
    Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
    MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative stabilities of IgG1 and IgG4 Fab domains: influence of the light-heavy interchain disulfide bond architecture.
    Heads JT; Adams R; D'Hooghe LE; Page MJ; Humphreys DP; Popplewell AG; Lawson AD; Henry AJ
    Protein Sci; 2012 Sep; 21(9):1315-22. PubMed ID: 22761163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How natalizumab binds and antagonizes α4 integrins.
    Yu Y; Schürpf T; Springer TA
    J Biol Chem; 2013 Nov; 288(45):32314-32325. PubMed ID: 24047894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
    Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
    Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low binding affinity and reduced complement-dependent cell death efficacy of ofatumumab produced using a plant system (Nicotiana benthamiana L.).
    Jin N; Lee JW; Heo W; Ryu MY; So MK; Ko BJ; Kim HY; Yoon SM; Lee J; Kim JY; Kim WT
    Protein Expr Purif; 2019 Jul; 159():34-41. PubMed ID: 30880170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the Fab fragment from F124, a monoclonal antibody specific for hepatitis B surface antigen.
    Saul FA; Vulliez-Le Normand B; Passafiume M; Riottot MM; Bentley GA
    Acta Crystallogr D Biol Crystallogr; 2000 Aug; 56(Pt 8):945-51. PubMed ID: 10944330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Native Reversible Self-Association of a Monoclonal Antibody Mediated by Fab-Fab Interaction.
    Gentiluomo L; Roessner D; Streicher W; Mahapatra S; Harris P; Frieß W
    J Pharm Sci; 2020 Jan; 109(1):443-451. PubMed ID: 31563513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crystal structure of the Fab fragment of a rat monoclonal antibody against the main immunogenic region of the human muscle acetylcholine receptor.
    Kontou M; Leonidas DD; Vatzaki EH; Tsantili P; Mamalaki A; Oikonomakos NG; Acharya KR; Tzartos SJ
    Eur J Biochem; 2000 Apr; 267(8):2389-97. PubMed ID: 10759865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dramatic activation of an antibody by a single amino acid change in framework.
    Liang WC; Yin J; Lupardus P; Zhang J; Loyet KM; Sudhamsu J; Wu Y
    Sci Rep; 2021 Nov; 11(1):22365. PubMed ID: 34785671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies.
    Donaldson JM; Zer C; Avery KN; Bzymek KP; Horne DA; Williams JC
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17456-61. PubMed ID: 24101516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity improvement of a therapeutic antibody by structure-based computational design: generation of electrostatic interactions in the transition state stabilizes the antibody-antigen complex.
    Kiyoshi M; Caaveiro JM; Miura E; Nagatoishi S; Nakakido M; Soga S; Shirai H; Kawabata S; Tsumoto K
    PLoS One; 2014; 9(1):e87099. PubMed ID: 24475232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.